BioSpace News Archive

Abcam plc, a global leader in the supply of life science research tools, will report its Interim Results for the six-month period ended 31 December 2020 at 12.00 p.m. GMT on Monday, March 8, 2021.

4D pharma to list ADSs on NASDAQ in conjunction with the merger agreement between 4D pharma and Longevity Acquisition Corp., a SPAC

Biophytis SA, a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from COVID-19, announces its non-audited financial results for the year ended December 31, 2020, and provides updates on key operational developments and financing transactions.

Safety data has been presented from the ongoing Phase I study with ATOR-1017 in patients with metastatic cancer.

Vela Diagnostics announced that it has added ViroKey™ SQ FLEX SARS-CoV-2 Genotyping Assay and ViroKey™ SARS-CoV-2 ID RT-PCR Test to its portfolio offering.

New online series of family stories from the global myotubular and centronuclear myopathy community highlights the challenges of those affected and their collective hopes for the future

Treatment with sargramostim was safe, well tolerated and generated T-cells targeted at the SARS-CoV-2 virus, indicating a COVID-19 specific immune response

Incyte announced the validation of the Company’s Marketing Authorization Application for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell anal carcinoma who have progressed on, or who are intolerant of, platinum-based chemotherapy.

China National Medical Products Administration announced on February 25 to grant conditional marketing authorization of Recombinant COVID-19 Vaccine .

Amneal Pharmaceuticals, Inc. announced its results for the fourth quarter and full year ended December 31, 2020.